CT2241/2026 - Framework Contract for the supply of Enoxaparin Sodium 100mg/mL Solution for Injection in Pre-Filled Syringes
TED · 502663-2026Contract noticeClosed 56 days ago
Value
Estimated€2,430,179 · 2,430,179 EUR
Awarded—
Who already wins at this buyer
Firms with recorded awards from Department of Contracts in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| E.J. BUSUTTIL LIMITED | 11 | €4,788,478 | 2026-10-14 |
| Drugsales Ltd | 5 | €3,258,805 | 2026-10-05 |
| V.J. Salomone Pharma Limited | 4 | €11,867,887 | 2026-06-24 |
| Vivian Corporation Ltd | 4 | €1,521,639 | 2026-10-19 |
| Mint Health Limited | 3 | €1,145,101 | 2026-06-09 |
Full buyer profile: what Department of Contracts buys and who wins it →
CPV codes
33621100 Medical equipment & pharmaceuticalsDescription
CT2241/2026 - Framework Contract for the supply of Enoxaparin Sodium 100mg/mL Solution for Injection in Pre-Filled Syringes
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-09-10 | CT2364/2026 - Framework Contract for the Supply of Nirsevimab Solution for Injection in Pre-filled Syringe/Pen | Department of Contracts MT | 94% |
| 2026-06-30 | CT2199/2026 - Framework Contract for supply of Doxapram Hydrochloride 20mg/mL Solution for Injection | Department of Contracts MT | 93% |
| 2026-09-11 | CT2073/2026 - Framework contract is the supply of Nirsevimab Solution for Injection in Pre-filled Syringe/Pen | Department of Contracts MT | 92% |
| 2026-06-12 | CT2214/2026 - Framework Contract for the supply of Adalimumab 40mg prefilled syringes/ pens | Department of Contracts MT | 92% |
| 2026-06-25 | CT2188/2026 - Framework Contract for the supply of Octreotide 20mg and 30mg injections | Department of Contracts MT | 92% |
| 2026-09-03 | CT2320/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF STERILE AND NON-STERILE PACKAGED PREFILLED 10ML 0.9 PERCENT SODIUM CHLORIDE SYRINGE | Department of Contracts MT | 92% |